Order Article Reprints

Hernandez Reyes JdlC, Santos Morales O, Hernandez Moreno L, Pino Alfonso PP, Neninger Vinageras E, Knigths Montalvo JL, Aguilar Sosa A, Gonzalez Morera A, Lorenzo-Luaces Alvárez P, Aguilar Venegas Y, et al. PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients. Vaccines. 2024; 12(8):833. https://doi.org/10.3390/vaccines12080833

Hernandez Reyes, Jenysbel de la C., Orestes Santos Morales, Laura Hernandez Moreno, Pedro Pablo Pino Alfonso, Elia Neninger Vinageras, Julia Lilliam Knigths Montalvo, Aliuska Aguilar Sosa, Amnely Gonzalez Morera, Patricia Lorenzo-Luaces Alvárez, Yadira Aguilar Venegas, and et al. 2024. "PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients" Vaccines 12, no. 8: 833. https://doi.org/10.3390/vaccines12080833

Hernandez Reyes, J. d. l. C., Santos Morales, O., Hernandez Moreno, L., Pino Alfonso, P. P., Neninger Vinageras, E., Knigths Montalvo, J. L., Aguilar Sosa, A., Gonzalez Morera, A., Lorenzo-Luaces Alvárez, P., Aguilar Venegas, Y., Troche Concepción, M., Medel Pérez, L., Santiesteban González, Y., García Fernández, L., Regueiro Rodríguez, L., Macías Abrahan, A., Labrada Mon, M., León Monzón, K., Saavedra Hernández, D., & Crombet Ramos, T. (2024). PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients. Vaccines, 12(8), 833. https://doi.org/10.3390/vaccines12080833